MétaCan
Menu
← Back to cohort

A National Survey and Needs Assessment on Choices of Therapeutic Agents for Chronic Idiopathic Constipation and Constipation Predominant Irritable Bowel Syndrome: A Canadian Perspective

2015· article· en· W2979135675 on OpenAlexaffabout
Yvonne Tse, Louis WC. Liu, Christopher Andrews, David A. Armstrong

Bibliographic record

VenueThe American Journal of Gastroenterology · 2015
Typearticle
Languageen
FieldMedicine
TopicGastrointestinal motility and disorders
Canadian institutionsUniversity of CalgaryMcMaster UniversityUniversity of TorontoUniversity Health Network
Fundersnot available
KeywordsMedicineIrritable bowel syndromeConstipationInternal medicineClinical PracticeTegaserodAgonistGastroenterologyPhysical therapy

Abstract

fetched live from OpenAlex

Introduction: Chronic Idiopathic Constipation (CIC) and constipation-predominant Irritable Bowel Syndrome (IBS-C) are common functional lower gastrointestinal disorders that impair patients' quality of life; despite this, therapies remain unsatisfactory to patients and treating physicians. In 2014, ACG and AGA published two clinical guidelines independently. In a national survey, we aim to evaluate: 1. Canadian gastroenterologists (GIs) practice patterns in the utilization of therapeutic agents listed in the two guidelines; 2. GIs satisfaction with these agents for their CIC and IBS-C patients; and 3. the usefulness of these new guidelines in their clinical practice. Methods: In February 2015, a 9-item questionnaire was sent to 350 Canadian GIs (Converge, Toronto, ON, Canada) to determine their practice demographic information and practice approaches to CIC and IBS-C management including stool softener, fibre supplement, stimulant and osmotic laxative, 5-HT4 agonist and guanylate cyclase-C (GCC) agonist therapies. The study closed in May 2015. Results: The response rate to the survey was 15% (n=52). Almost all (96%) responders follow a standard, stepwise approach for managing patients with CIC and IBS-C. However, they believe that only 23% of referring physicians follow the same approach. Reported first-line therapy (osmotic laxatives) was similar for IBS-C and CIC but second-line therapy differed for CIC (bulking agents) and IBS-C (GCC agonist). Nearly 80% of responders indicated that GCC agonists were the most satisfactory therapy for IBS-C and CIC; despite this, 61% of responders and 64% of referring physicians (reported by the responders) are reluctant to move from over-the-counter to prescription agents. Among the 68% of responders who are aware of the 2 published guidelines, only 51% found the guidelines helpful in prioritizing treatment choices, and 69% of responders indicated that a treatment algorithm, applicable to Canadian practice, would be valuable. Conclusion: This survey demonstrates a need for an education program to standardize and enhance the treatment of CIC and IBS-C. The majority of Canadian GIs would welcome a practical management algorithm to translate new published guidelines and the role of new therapeutic agents into clinical practice. Based on this needs assessment, a comprehensive treatment algorithm has been developed and will be evaluated for the management of IBS-C and CIC in Canadian practice.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.028
Threshold uncertainty score0.204

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0020.008
Science and technology studies0.0030.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.326
Teacher spread0.287 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes2
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicGastrointestinal motility and disorders→French-language works237,207→